E2 levels are also known to be involved in the development of some cancers, with some estrogen receptor α (ERα)-positive stromal cells increasing E2 expression (5), which may promote the progression of cervical and breast cancers in both non-pregnant and pregnant patients via its induction of the MDSCs (6). Here, ESR1 is linked to breast carcinoma.